Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. (Q33369276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yoon Soo Chang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Si Young Song

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mi-Suk Park

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jeong-Sik Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dong Sup Yoon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Yong Han Paik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Se Joon Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dong-Ki Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jae Bock Chung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2753-2758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16294346%20AND%20SRC:MED&resulttype=core&format=json

Biliary carcinoma. A review of 109 cases

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

A phase II study of gemcitabine in gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

Is carcinoma of the gallbladder a curable lesion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021

Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021

Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21591

7 January 2021